Found 8 matching trials
Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056
PHASE2The purpose of this study is to evaluate the long term safety and tolerabil...
A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease
PHASE2The primary purpose of this multi-centre, double blind-study is to evaluate...
Location
Multiple Locations
Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy
PHASE2The primary objective of this study is to evaluate the efficacy and safety ...
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
PHASE2The purpose of this study is to evaluate the safety, efficacy, pharmacokine...
The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis
PHASE2The purpose of this study is to evaluate the long-term safety and tolerabil...
The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males
PHASE1To evaluate the safety, tolerability, blood levels and effects of CDP6038 a...
Location
Multiple Locations
Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects
PHASE1To evaluate the safety and tolerability of CDP6038 following single dose su...
Location
Multiple Locations
To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate
PHASE1The primary objectives are to determine the relationship between blood leve...
Location
Multiple Locations